InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Friday, 03/18/2022 8:24:35 PM

Friday, March 18, 2022 8:24:35 PM

Post# of 14947
Even the FOOL says...
"The trial results were certainly encouraging, particularly given that Semdexa is a non-opioid treatment and thus does not carry the risks associated with that class of medicines. It should stand a good chance of winning FDA approval."

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News